Cargando…
Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma
Fusion genes have been identified as oncogenes in several solid tumors including lung, colorectal, and stomach cancers. Here, we characterized the fusion gene, VAPA-Rab31, discovered from RNA-sequencing data of a patient with lung adenocarcinoma who did not harbor activating mutations in EGFR, KRAS...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539523/ https://www.ncbi.nlm.nih.gov/pubmed/31083279 http://dx.doi.org/10.3390/ijms20092309 |
_version_ | 1783422409102065664 |
---|---|
author | Yoon, Daseul Bae, Kieun Kim, Jin-Hee Choi, Yang-Kyu Yoon, Kyong-Ah |
author_facet | Yoon, Daseul Bae, Kieun Kim, Jin-Hee Choi, Yang-Kyu Yoon, Kyong-Ah |
author_sort | Yoon, Daseul |
collection | PubMed |
description | Fusion genes have been identified as oncogenes in several solid tumors including lung, colorectal, and stomach cancers. Here, we characterized the fusion gene, VAPA-Rab31, discovered from RNA-sequencing data of a patient with lung adenocarcinoma who did not harbor activating mutations in EGFR, KRAS and ALK. This fusion gene encodes a protein comprising the N-terminal region of vesicle-associated membrane protein (VAMP)-associated protein A (VAPA) fused to the C-terminal region of Ras-related protein 31 (Rab31). Exogenous expression of VAPA-Rab31 in immortalized normal bronchial epithelial cells demonstrated the potential transforming effects of this fusion gene, including increased colony formation and cell proliferation in vitro. Also, enhanced tumorigenicity upon VAPA-Rab31 was confirmed in vivo using a mouse xenograft model. Metastatic tumors were also detected in the liver and lungs of xenografted mice. Overexpression of VAPA-Rab31 upregulated anti-apoptotic protein Bcl-2 and phosphorylated CREB both in cells and xenograft tumors. Reduced apoptosis and increased phosphorylation of CREB and Erk were observed in VAPA-Rab31-overexpressing cells after bortezomib treatment. Elevated Bcl-2 level via activated CREB contributed to the resistance to the bortezomib-induced apoptosis. Our data suggest the oncogenic function of the novel fusion gene VAPA-Rab31 via upregulated Bcl-2 and activated CREB in lung cancer. |
format | Online Article Text |
id | pubmed-6539523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65395232019-06-04 Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma Yoon, Daseul Bae, Kieun Kim, Jin-Hee Choi, Yang-Kyu Yoon, Kyong-Ah Int J Mol Sci Article Fusion genes have been identified as oncogenes in several solid tumors including lung, colorectal, and stomach cancers. Here, we characterized the fusion gene, VAPA-Rab31, discovered from RNA-sequencing data of a patient with lung adenocarcinoma who did not harbor activating mutations in EGFR, KRAS and ALK. This fusion gene encodes a protein comprising the N-terminal region of vesicle-associated membrane protein (VAMP)-associated protein A (VAPA) fused to the C-terminal region of Ras-related protein 31 (Rab31). Exogenous expression of VAPA-Rab31 in immortalized normal bronchial epithelial cells demonstrated the potential transforming effects of this fusion gene, including increased colony formation and cell proliferation in vitro. Also, enhanced tumorigenicity upon VAPA-Rab31 was confirmed in vivo using a mouse xenograft model. Metastatic tumors were also detected in the liver and lungs of xenografted mice. Overexpression of VAPA-Rab31 upregulated anti-apoptotic protein Bcl-2 and phosphorylated CREB both in cells and xenograft tumors. Reduced apoptosis and increased phosphorylation of CREB and Erk were observed in VAPA-Rab31-overexpressing cells after bortezomib treatment. Elevated Bcl-2 level via activated CREB contributed to the resistance to the bortezomib-induced apoptosis. Our data suggest the oncogenic function of the novel fusion gene VAPA-Rab31 via upregulated Bcl-2 and activated CREB in lung cancer. MDPI 2019-05-10 /pmc/articles/PMC6539523/ /pubmed/31083279 http://dx.doi.org/10.3390/ijms20092309 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoon, Daseul Bae, Kieun Kim, Jin-Hee Choi, Yang-Kyu Yoon, Kyong-Ah Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title | Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title_full | Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title_fullStr | Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title_full_unstemmed | Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title_short | Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma |
title_sort | oncogenic effect of the novel fusion gene vapa-rab31 in lung adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539523/ https://www.ncbi.nlm.nih.gov/pubmed/31083279 http://dx.doi.org/10.3390/ijms20092309 |
work_keys_str_mv | AT yoondaseul oncogeniceffectofthenovelfusiongenevaparab31inlungadenocarcinoma AT baekieun oncogeniceffectofthenovelfusiongenevaparab31inlungadenocarcinoma AT kimjinhee oncogeniceffectofthenovelfusiongenevaparab31inlungadenocarcinoma AT choiyangkyu oncogeniceffectofthenovelfusiongenevaparab31inlungadenocarcinoma AT yoonkyongah oncogeniceffectofthenovelfusiongenevaparab31inlungadenocarcinoma |